Healthcare player, Zydus Group on Monday announced acquisition of Actibile from Albert David Limited through its flagship company, Cadila Healthcare Limited. The company has entered into a definitive agreement to acquire the gastroenterology segment, which is used for dissolving gall bladder stones.
The company did not disclose the value of the transaction. However, it stated that the deal, which would strengthen Zydus' presence in the gastroenterology segment, will be financed through internal accruals.
Speaking on the development, Chairman and Managing Director of the group, Pankaj R. Patel said, "The gastrointestinal segment has been one of our core focus segments and we have been working with the medical fraternity to serve patient needs better. I believe that this acquisition will strengthen our portfolio of brands and leverage our equity in this key segment."
The shares of Cadila Healthcare fell by 0.44 per cent to close at Rs 318.90 on the Bombay Stock Exchange (BSE) on Monday.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.